Story – P95

Our story

P95 delivers cutting-edge expertise in epidemiology and pharmacovigilance. We are passionate about healthcare and help our customers with innovative medical research. We share a sense of urgency with our customers to deliver timely, pragmatic and useful insights to improve healthcare.

2011

2011P95 was established by Thomas Verstraeten in June 2011 as a small-medium enterprise. Initially, the company was a small <5-employee family firm providing highly specialized consultancy services in the field of pharmacovigilance and epidemiology.

2015In 2015, P95 established a data analytics center, resulting from the company’s response to the increasing demand of the vaccine industry in the field of data analysis.

2021

2021After 10 years of existence and reacting to the challenges of the COVID-19 pandemic, P95’s growth led to its expansion to new countries/regions. In 2021, P95 acquired the Dutch company Pallas health research and consulting and established P95 Latina, with a new office in Colombia.

2023In early 2023, with >100 employees, P95 has set up a new office in Bangkok, Thailand. In May, P95 received a majority recapitalization by Ampersand Capital Partners. In October, OnQ Research merged with P95, thereby expanding P95’s geographical range to Africa and enhancing its portfolio with valuable clinical trial experience. With offices in four different continents, P95 is now more equipped to conduct new studies and explore new markets in Latin America, Europe, Africa and Asia

Our story

Privacy – Cookies – LinkedIn